Drug Trial Radar · NCT00474630
A Safety and Efficacy Study Comparing Naltrexone SR/Bupropion SR and Placebo in Obese Subjects With Type 2 Diabetes
Last checked: Nov 20, 2026Latest source record: Nov 21, 2014 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
505
Actual
Start
May 2007
Primary completion
Jun 2009
Study completion Jun 2009
Sponsor
- Lead sponsor
- Orexigen Therapeutics, IncIndustry
- Sponsor type
- Industry
- First posted
- May 17, 2007
Design
- Study type
- Interventional
- Phase
- Phase 3
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Triple (participant, investigator, outcomes assessor)
- Primary purpose
- Treatment
- Who can join
- All sexes, from 18 years, up to 70 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The purpose of this study is determine whether the combination of naltrexone SR and bupropion SR is safe and effective in treating obesity in subjects with type 2 diabetes.
Conditions
- Obesity
- Overweight
- Diabetes Mellitus, Type 2
Interventions
Naltrexone SR 32 mg/bupropion SR 360 mg/ dayDrug
PlaceboDrug
Ancillary therapyBehavioral
Ancillary therapy consisting of diet instruction, advice on behavior modification, and exercise counseling
Primary outcomes
What the sponsor says the trial is designed to measure.
- Co-primary: Body Weight- Mean Percent ChangeTime frame: Baseline, 56 weeks
- Co-primary: Body Weight- Proportion of Subjects With ≥5% DecreaseTime frame: Baseline, 56 weeks
Locations
53 sites in 1 country. Site status is shown where the registry gives one.
SelfCenter, PC
Fairhope, Alabama
Pivotal Research Centers
Peoria, Arizona
HOPE Research Institute
Phoenix, Arizona
HealthStar Research
Hot Springs, Arkansas
Impact Clinical Trials
Beverly Hills, California
Northern California Research
Carmichael, California
Sierra Medical Research
Fresno, California
Advance Clinical Research Institute
Orange, California
Affiliated Research Institute
San Diego, California
VA San Diego Healthcare System
San Diego, California
Apex Research Institue
Santa Ana, California
Chase Medical Research, LLC
Waterbury, Connecticut
LCFP Inc.
Fort Myers, Florida
Miami Research Associates
Miami, Florida
Suncoast Clinical Research
Palm Harbor, Florida
University Clinical Research
Pembroke Pines, Florida
CSRA Partners in Health, Inc
Augusta, Georgia
East-West Medical Research Institute
Honolulu, Hawaii
Deaconess Clinic
Evansville, Indiana
Northwest Indiana Center for Clinical Research
Valparaiso, Indiana
Central Kentucky Research Associates, Inc.
Lexington, Kentucky
L-Marc
Louisville, Kentucky
Trover Center for Clinical Studies
Madisonville, Kentucky
Pennington Biomedical Research Center
Baton Rouge, Louisiana
Medical Research Institute
Slidell, Louisiana
Health Trends Research, LLC
Baltimore, Maryland
FutureCare Studies
Springfield, Massachusetts
Twin Cities Clinical Research
Brooklyn Center, Minnesota
The Center for Pharmaceutical Research
Kansas City, Missouri
Mercy Health Research
St Louis, Missouri
Radiant Research, Inc.
St Louis, Missouri
Center for Nutrition and Metabolic Diseases, Univ. of Nevada
Reno, Nevada
Endocrinology & Diabetes Consultants
Dover, New Hampshire
Lovelace Scientific Resources
Albuquerque, New Mexico
Diabetes care and Information Center
Flushing, New York
Central New York Clinical Research
Manlius, New York
Rochester Clinical Research, Inc
Rochester, New York
Metrolina Medical Research
Charlotte, North Carolina
Rapid Medical Research, Inc.
Cleveland, Ohio
Central Ohio Nutrition Center, Inc.
Columbus, Ohio
Showing 40 of 53 sites, US sites first. The full list is on the registry record.
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.